Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innolact Group is a Finnish biotechnology company specializing in precision fermentation and bioprocess development. The company provides comprehensive services in yeast and bacteria cell line development, supporting the production of recombinant proteins, vaccines, biopharmaceuticals, and biosimilars. Based in Kuopio, Innolact leverages its expertise in fermentation and dairy science to assist partners in the life sciences and food technology sectors with process optimization, quality control, and GMP training. The company is a key participant in the Finnish synthetic biology ecosystem, collaborating with research institutions to advance sustainable bioproduction technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innolact Group.